Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor? - Claus, Benedikt Bernd; Specka, Michael; McAnally, Heath; Scherbaum, Norbert; Schifano, Fabrizio; Bonnet, Udo (Frontiers in psychiatry, 2020)
Keywords: cannabis withdrawal syndrome subtypes; gender effect; inpatient detoxification treatment; protracted withdrawal syndrome; Psychiatry; urinary 11-nor-9-carboxy-delta9-tetrahydrocannabinol; cannabis withdrawal syndrome subtypes; protracted withdrawal syndrome; urinary 11-nor-9-carboxy-delta9-tetrahydrocannabinol; gender effect; inpatient detoxification treatment